Future Financial Wealth Management’s Apellis Pharmaceuticals APLS Stock Holding History

Future Financial Wealth Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$8.65K	–	462
2025 Q2	$8.65K	Hold	500	–	–	0.01%	377
2025 Q1	$10.9K	Hold	500	–	–	0.01%	363
2024 Q4	$16K	Hold	500	–	–	0.01%	342
2024 Q3	$14.4K	Buy	+500	New	+$18.5K	0.01%	363
2024 Q2	–	Sell	-500	Closed	-$29.4K	–	133
2024 Q1	$29.4K	Buy	+500	New	+$31.9K	0.02%	311
2022 Q2	–	Sell	-500	Closed	-$25K	–	142
2022 Q1	$25K	Hold	500	–	–	0.02%	341
2021 Q4	$24K	Buy	+500	New	+$19.7K	0.02%	352

Other funds holding APLS

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Future Financial Wealth Management's APLS Position: Q3 2025 in Review

Future Financial Wealth Management sold out of Apellis Pharmaceuticals (APLS) in Q3 2025, closing a stake of 500 shares — an estimated $8.65K sold.

Future Financial Wealth Management first reported a position in APLS in Q4 2021 and held it in 7 quarters. The position peaked at $29.4K in Q1 2024. 273 funds tracked by Wall St. Rank hold APLS as of Q3 2025.

Future Financial Wealth Management reported no remaining Apellis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Future Financial Wealth Management sold 500 Apellis Pharmaceuticals shares in Q3 2025, an estimated $8.65K.
Future Financial Wealth Management first reported a position in Apellis Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Future Financial Wealth Management's Apellis Pharmaceuticals position peaked at $29.4K in Q1 2024.
273 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2025.

Based on Future Financial Wealth Management's 13F filing for Q3 2025, filed 15 Oct 2025.